Acyclovir Improves the Efficacy of Chemoradiation in Nasopharyngeal Cancer Containing the Epstein Barr Virus Genome
A. Thandoni, A. Zloza, D. Schiff, M. Rao, K.-w. Lo, B. G. Haffty, S. Kim, S. R. Jhawar
This study shows that adding acyclovir to chemoradiation reduces viability of EBV-infected NPC cells by increasing TK and apoptosis markers.
bioRxiv · Oct 18, 2020 · PreprintCancer Biology